Adult blood lead epidemiology and surveillance - United States, first quarter, 1998, and annual 1994-1997.
Lofgren-JP; Schaller-K; Payne-S; Jung-BC; Gergely-R; Davis-W; Keyvan-Larijani-E; Rabin-R; Allemier-A; Falken-M; DeLaurier-C; Gerwel-B; Prophet-R; Stone-R; Randolph-S; Migliozzi-A; Rhoades-E; Sandoval-A; Gostin-J; Stoeckel-M; Gardner-Hillian-A; Salzman-D; Ball-W; Toof-L; Rajaraman-P; Tierney-J; Klietz-T
MMWR 1998 Oct; 47(42):907-911
CDC, in collaboration with state and local health departments, monitors laboratory-reported elevated blood lead levels (BLLs) among adults in the United States. During 1998, 27 states * reported surveillance data to the Adult Blood Lead Epidemiology and Surveillance (ABLES) program. This report presents ABLES data for the first quarter of 1998 compared with the first quarter of 1997, annual data for 1997 compared with 1996, and prevalence and incidence of elevated BLLs from 1994 through 1997. The findings indicate that approximately 4000 adults per quarter and an estimated 12,000 adults per year continue to have elevated BLLs; there does not appear to be a trend in these data from 1994 through 1997.
Lead-absorption; Lead-compounds; Lead-dust; Blood-analysis; Blood-sampling; Central-nervous-system-disorders; Blood-disorders; Reproductive-system-disorders; Cardiovascular-system-disorders; Kidney-disorders; Environmental-exposure; Exposure-levels; Exposure-limits; Neurotoxic-effects; Surveillance-programs; Region-1; Region-10; Region-2; Region-3; Region-4; Region-5; Region-6; Region-7; Region-8; Region-9
Morbidity and Mortality Weekly Report
AL; CA; AZ; CT; IA; ME; MD; MA; MI; MN; NH; NJ